Alzheimer Disease
Clinical development commences for AZD-103 for Alzheimer disease
Published in Biotech Business Week, November 7th, 2005
The AZD-103 compound is, according to the companies, a promising disease-modifying therapeutic candidate for the treatment of Alzheimer disease.
This class of therapeutics provides significant advantages over the current products on the market which only treat disease symptoms, according to the companies.
Strong preclinical data have confirmed AZD-103's excellent safety profile and potential as a disease-modifying therapeutic for the treatment of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Assisted Reproduction
Two live births from the world's longest successfully stored sperm announced - Genetics & Genomics
Micorarray processing company expands Affymetrix capabilities - Genomics Research
Diagnostics company launches novel system for high-throughput DNA sequencing - Stem Cell Research
Alternative approach reported for derivation of embryonic stem cell lines - Age-Related Macular Degeneration
U.S. FDA agrees to statistical analysis and filing plans for company's RHEO System - Alzheimer Disease
Study shows protein test improves early detection, diagnosis of Alzheimer disease - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
